Literature DB >> 36197654

Reevaluating Liver Donor Risk in the Era of Improved Hepatitis C Virus Treatment.

Thomas J Handley1,2, Katherine Arnow2, Kazunari Sasaki3, Allison Kwong4, Marc L Melcher3.   

Abstract

Entities:  

Year:  2022        PMID： 36197654      PMCID： PMC9535494          DOI： 10.1001/jamasurg.2022.3922

Source DB:  PubMed          Journal:  JAMA Surg        ISSN： 2168-6254            Impact factor:   16.681


× No keyword cloud information.
  4 in total

1.  The Current State of Liver Transplantation in the United States: Perspective From American Society of Transplant Surgeons (ASTS) Scientific Studies Committee and Endorsed by ASTS Council.

Authors:  S A Fayek; C Quintini; K D Chavin; C L Marsh
Journal:  Am J Transplant       Date:  2016-10-03       Impact factor: 8.086

2.  Characteristics associated with liver graft failure: the concept of a donor risk index.

Authors:  S Feng; N P Goodrich; J L Bragg-Gresham; D M Dykstra; J D Punch; M A DebRoy; S M Greenstein; R M Merion
Journal:  Am J Transplant       Date:  2006-04       Impact factor: 8.086

3.  Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors.

Authors:  Allison J Kwong; Anji Wall; Marc Melcher; Uerica Wang; Aijaz Ahmed; Aruna Subramanian; Paul Y Kwo
Journal:  Am J Transplant       Date:  2018-11-26       Impact factor: 8.086

4.  Trends in Discard of Kidneys from Hepatitis C Viremic Donors in the United States.

Authors:  Su-Hsin Chang; Massini Merzkani; Krista L Lentine; Mei Wang; David A Axelrod; Siddiq Anwar; Mark A Schnitzler; Jason Wellen; William C Chapman; Tarek Alhamad
Journal:  Clin J Am Soc Nephrol       Date:  2021-01-15       Impact factor: 8.237
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.